These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11754670)

  • 1. Cervical cancer screening in developing countries.
    Suba EJ; Raab SS
    JAMA; 2001 Dec; 286(24):3079-81. PubMed ID: 11754670
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for cervical cancer in low-resource settings in 2011.
    Tambouret R
    Arch Pathol Lab Med; 2013 Jun; 137(6):782-90. PubMed ID: 23721273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo establishment and cost-effectiveness of Papanicolaou cytology screening services in the Socialist Republic of Vietnam.
    Levin CE; Sellors JW
    Cancer; 2002 Apr; 94(8):2312-4; author reply 2314-6. PubMed ID: 12001136
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost-effectiveness of cervical-cancer screening in developing countries.
    Suba EJ; Frable WJ; Raab SS
    N Engl J Med; 2006 Apr; 354(14):1535-6; author reply 1535-6. PubMed ID: 16598056
    [No Abstract]   [Full Text] [Related]  

  • 5. Is a once-in-a-lifetime pap smear the best option for low-resourced settings?
    Robles SC
    Int J Cancer; 2004 Aug; 111(1):160-1; discussion 162. PubMed ID: 15185358
    [No Abstract]   [Full Text] [Related]  

  • 6. De novo establishment and cost-effectiveness of Papanicolaou cytology screening services in the Socialist Republic of Vietnam.
    Suba EJ; Nguyen CH; Nguyen BD; Raab SS;
    Cancer; 2001 Mar; 91(5):928-39. PubMed ID: 11251944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chapter 8: Screening for cervical cancer in developing countries.
    Denny L; Quinn M; Sankaranarayanan R
    Vaccine; 2006 Aug; 24 Suppl 3():S3/71-7. PubMed ID: 16950020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of cancer of the cervix in low- and middle-income countries.
    Denny L
    Ann Surg Oncol; 2015 Mar; 22(3):728-33. PubMed ID: 25605513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cost effectiveness of cervical cancer screening strategies in Tunisia].
    Hsaïri M; Fakhfakh R; Ghyoula M; Ben Abdallah M; Achour N
    Tunis Med; 2000 Oct; 78(10):557-61. PubMed ID: 11190738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective screening programmes for cervical cancer in low- and middle-income developing countries.
    Sankaranarayanan R; Budukh AM; Rajkumar R
    Bull World Health Organ; 2001; 79(10):954-62. PubMed ID: 11693978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alliance for cervical cancer prevention: setting the record straight.
    Sherris J; Wright TC; Denny L; Sankaranarayanan R; Pollack AE; Sanghvi H; Sellors JW
    Am J Public Health; 2007 Feb; 97(2):200-1; author reply 201-202. PubMed ID: 17194847
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cost effectiveness of human papilloma virus testing in cervical cancer screening: a literature review].
    Mejía A; Salas W
    Biomedica; 2008 Mar; 28(1):160-72. PubMed ID: 18645671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical screening by visual inspection with acetic acid.
    Szarewski A
    Lancet; 2007 Aug; 370(9585):365-6. PubMed ID: 17678998
    [No Abstract]   [Full Text] [Related]  

  • 14. Preventing cervical cancer in the developing world.
    Katz IT; Wright AA
    N Engl J Med; 2006 Mar; 354(11):1110. PubMed ID: 16540609
    [No Abstract]   [Full Text] [Related]  

  • 15. Cervical screening program for Sri Lanka--can we afford it?
    Sirisena J
    Ceylon Med J; 1999 Mar; 44(1):41-5. PubMed ID: 10643099
    [No Abstract]   [Full Text] [Related]  

  • 16. Reconsidering the feasibility of papanicolaou and alternative screening tests for low-resource countries.
    Tsu VD
    Am J Public Health; 2007 Feb; 97(2):199; author reply 199-200. PubMed ID: 17194850
    [No Abstract]   [Full Text] [Related]  

  • 17. A theory-aided dissemination strategy for emerging technologies in cervical cancer screening.
    Shinn E; Basen-Engquist K; Crain B; Follen M
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S35-9. PubMed ID: 17870151
    [No Abstract]   [Full Text] [Related]  

  • 18. [Model program for the prevention and detection of gynecologic cancer in developing countries].
    Goes JS; Goes JC
    Bol Oficina Sanit Panam; 1980 Nov; 89(5):397-408. PubMed ID: 6452131
    [No Abstract]   [Full Text] [Related]  

  • 19. Innovative approaches to cervical cancer prevention.
    Blumenthal PD; Ringers P; McIntosh N; Gaffikin L
    Medscape Womens Health; 2001 Dec; 6(6):1. PubMed ID: 11965215
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytological screening for cervical cancer--what are its opportunity costs?
    Bloch B; Denny L; Nevin J; Dehaeck K; Whittaker J; Soeters R
    S Afr Med J; 1997 May; 87(5):615; author reply 615, 618. PubMed ID: 9254827
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.